How to Help Your Patients Save Money on Anoro Ellipta: A Provider's Guide to Savings Programs in 2026

Medication adherence is one of the most powerful predictors of COPD outcomes. Yet at $400–$600 per inhaler without insurance, Anoro Ellipta (umeclidinium/vilanterol) presents a real financial barrier for many patients — particularly those on Medicare or without adequate prescription coverage.

When patients can't afford their maintenance inhaler, they skip doses, stretch inhalers beyond their expiration date, or discontinue therapy entirely — all of which increase exacerbation risk, emergency department visits, and hospitalizations. Proactively addressing cost in your clinical workflow can prevent these outcomes.

This guide gives you a complete toolkit: from prescribing strategies that reduce cost, to savings programs you can refer patients to, to formulary navigation when insurance creates barriers.

Understanding Anoro Ellipta Costs in 2026

Key pricing facts to know when counseling patients:

• Brand Anoro Ellipta (retail): $400–$600 per 30-day inhaler (60 blisters)
• With GoodRx or discount card: Approximately $270–$340 per inhaler
• Commercial insurance coverage: ~91% of commercial plans cover Anoro Ellipta; typical copay $30–$100/month
• Medicare Part D coverage: ~79% of Part D plans cover Anoro Ellipta; costs vary widely by plan tier and coverage stage
• Authorized generic (Prasco Labs, launched 2025): Often placed on a lower insurance tier; may have lower copays for both commercial and Medicare patients

Strategy 1: Prescribe by Generic Name

The single highest-impact prescribing change you can make for Anoro Ellipta patients is prescribing by generic name: "umeclidinium/vilanterol 62.5/25 mcg inhalation powder."

Benefits:

• Allows pharmacists to dispense either brand Anoro Ellipta OR the Prasco authorized generic, whichever is in stock
• Many insurance plans have placed the generic on a lower formulary tier, reducing patient copays
• Improves fill success if brand is out of stock at the pharmacy

The generic is bioequivalent — same drug, same device, same dose. No clinical tradeoff.

Strategy 2: Prescribe a 90-Day Supply with Mail Order

A 90-day supply prescription:

• Enables mail-order pharmacy access, which often carries lower per-unit copays than retail
• Reduces frequency of refill barriers and patient pharmacy trips
• Particularly beneficial for elderly or mobility-limited COPD patients who rely on others for transportation
• Helps prevent gaps in therapy that lead to exacerbations

Strategy 3: The GSK For You Patient Assistance Program

For uninsured or underinsured patients who are financially eligible, the GSK For You Patient Assistance Program (PAP) provides Anoro Ellipta at no cost. This is your highest-impact option for patients who have no prescription coverage.

Program details:

• Contact: 1-888-825-5249 or gskpaf.org
• Patient requirements: Uninsured or underinsured, income below program thresholds
• Provider requirements: Submit a signed prescription; patient authorization for information release

Your office staff can significantly expedite this process by collecting patient financial information and the signed prescription at the time of the visit.

Strategy 4: Discount Cards for Underinsured Patients

For patients who don't qualify for the PAP or who need an immediate solution while assistance is pending, prescription discount cards are a practical bridge:

• GoodRx: Reduces Anoro Ellipta from ~$535 to approximately $270 at some pharmacies. Free, no registration required.
• SingleCare: Competitive discount rates at many pharmacy chains nationwide.

Important caveat for your patients: Discount cards are not insurance and generally cannot be combined with insurance benefits. If the discount card price is lower than their insurance copay, patients can use it directly at the pharmacy counter — but they cannot submit the claim to insurance simultaneously.

Strategy 5: Medicare Part D Navigation

For Medicare patients, consider these approaches:

• $2,100 out-of-pocket cap: As of 2026, Medicare Part D has a $2,100 annual OOP cap. For patients who reach catastrophic coverage, their costs drop to $0. This is particularly relevant for COPD patients on multiple expensive medications.
• Extra Help / Low-Income Subsidy (LIS): Medicare patients with limited income and resources may qualify for Extra Help, which significantly reduces Part D premiums, deductibles, and copays. Direct eligible patients to SSA.gov or call 1-800-772-1213 to apply.
• Annual formulary review: Medicare Part D formularies change annually. Patients whose plan now covers the authorized generic at a lower tier may benefit from medication changes or plan shopping during open enrollment.

Strategy 6: Office Samples as a Bridge

GSK sales representatives supply sample inhalers to prescribing offices. If your practice receives GSK samples, consider using them to:

• Bridge patients while a prior authorization is being processed
• Bridge patients while they wait for GSK PAP approval
• Allow patients to try Anoro Ellipta before committing to a prescription, reducing refill waste for patients who don't tolerate the medication

Strategy 7: Consider Lower-Cost Therapeutic Alternatives When Appropriate

If cost barriers persist despite all assistance programs, consider whether a lower-cost alternative is clinically appropriate for your patient. For patients with milder COPD (GOLD Stage I-II with few symptoms), LAMA monotherapy with generic tiotropium may be a clinically appropriate and significantly more affordable option. Discuss the trade-off in dual bronchodilation efficacy with your patient.

A Resource for Your Patients

Provide patients with our patient-facing Anoro Ellipta savings guide which covers all the same options from a patient perspective. If patients are also struggling to find Anoro Ellipta in stock, medfinder for providers can help locate in-stock pharmacies near your patients.

Provider Summary: Anoro Ellipta Cost Reduction Toolkit

• Prescribe generically: "umeclidinium/vilanterol 62.5/25 mcg" unlocks both brand and generic inventory
• Prescribe 90-day supply: Enables mail order and reduces per-unit cost
• GSK For You PAP: Free medication for uninsured/income-eligible patients — 888-825-5249 or gskpaf.org
• GoodRx/discount cards: $270–$340/inhaler without insurance — useful bridge for any patient
• Medicare Extra Help: Direct income-eligible patients to SSA.gov to apply
• Office samples: Request from GSK rep for bridging during PA processing or PAP approval